The Essential Guide to N-of-1 Trials in Health 2015
DOI: 10.1007/978-94-017-7200-6_17
|View full text |Cite
|
Sign up to set email alerts
|

Where Are N-of-1 Trials Headed?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 33 publications
0
5
0
Order By: Relevance
“…In the context of N-of-1 trials (which could be understood as a specific kind of SCED more common in medical research; Nikles & Mitchell, 2015, Tate & Perdices, 2019, it has been recommended that "all statistical methods planned-from visual representation to meta-analysis-should be described in the protocol" (Porcino et al, 2020, p. 10), including effect sizes, statistical significance, ways of performing sensitivity analyses, and how heterogeneity between participants will be assessed. In the SCED context, the importance of explicitly describing the expected data pattern and the expected effect of the intervention has also been recently emphasized (Maggin et al, 2020).…”
Section: A Priori Aspects To Include In the Data Analytic Planmentioning
confidence: 99%
“…In the context of N-of-1 trials (which could be understood as a specific kind of SCED more common in medical research; Nikles & Mitchell, 2015, Tate & Perdices, 2019, it has been recommended that "all statistical methods planned-from visual representation to meta-analysis-should be described in the protocol" (Porcino et al, 2020, p. 10), including effect sizes, statistical significance, ways of performing sensitivity analyses, and how heterogeneity between participants will be assessed. In the SCED context, the importance of explicitly describing the expected data pattern and the expected effect of the intervention has also been recently emphasized (Maggin et al, 2020).…”
Section: A Priori Aspects To Include In the Data Analytic Planmentioning
confidence: 99%
“…Representing results and selecting the most appropriate statistical analysis. To access an overview of statistical analysis available for SCEDs, readers can refer to Manolov and Moeyaert 60,61 or to the specific options for N‐of‐1 trials 1,14 . Abbreviations: MBD, multiple‐baseline design; SCED, single‐case experimental design.…”
Section: Baseline Features Are Crucial To All Scedsmentioning
confidence: 99%
“…to answer the question ‘does this intervention help?’ 12 ), whenever feasible, multiple (i.e. aggregated) N‐of‐1 trials should be preferred to other SCEDs and to group randomized controlled trials (RCTs), because they (1) have a higher level of evidence according to the Oxford Centre for Evidence‐Based Medicine; 12 (2) increase power at the group level; 13 (3) provide a personalized statistical significance at the single‐participant level; (4) rely on multiple trials on the same participant, so they are more relevant to the participant than decisions based on the mean expected responses, inferred from the best quality RCT meta‐analysis; (5) may contribute to increased participant confidence and commitment to long‐term management 14 . As high‐quality guidelines already cover all the important themes for N‐of‐1 trials, 1,14 and because N‐of‐1 methodology is well recognized, 15,16 this paper will focus mainly, but not exclusively, on MBD.…”
Section: Figurementioning
confidence: 99%
“…Comparisons of treatment efficacy should thus be performed within blocks. This randomly determined sequence is equivalent to the N-of-1 trials used in the health sciences (Nikles & Mitchell, 2015), where the several random-order AB blocks are called multiple crossovers. It is possible (and in the health sciences common) to replicate the series across several participants, each with its own randomly determined sequence.…”
Section: The Proposals Are Applicable To Different Single-case Experi...mentioning
confidence: 99%